The natural history of acute rheumatic fever in Kuwait: A prospective six year follow-up report

Majeed, H. A.; Yousof, A. M.; Khuffash, Faisal A.; Yusuf, Abdul Razak; Farwana, S; Khan, Nazir

doi:10.1016/0021-9681(86)90122-0

Cited by 43 publications

(17 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients who have had rheumatic carditis, with or without valvular disease, are at a relatively high risk for recurrences of carditis and are likely to sustain increasingly severe cardiac involvement with each recurrence. 5,6,68 Therefore, patients who have had rheumatic carditis should receive long-term antibiotic prophylaxis well into adulthood and perhaps for life (Class I, LOE C). For patients with persistent valvular disease, the committee recommends prophylaxis for 10 years after the last episode of acute rheumatic fever or until 40 years of age (whichever is longer).…”

Section: Duration Of Prophylaxismentioning

confidence: 99%

See 1 more Smart Citation

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

Gerber¹,

et al. 2009

View full text Add to dashboard Cite

Abstract-Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A ␤-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by combining clinical judgment with diagnostic test results, the criterion standard of which is the throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) is the treatment of choice, because it is cost-effective, has a narrow spectrum of activity, and has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. For penicillin-allergic individuals, acceptable alternatives include a narrow-spectrum oral cephalosporin, oral clindamycin, or various oral macrolides or azalides. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The recommended duration of prophylaxis depends on the number of previous attacks, the time elapsed since the last attack, the risk of exposure to GAS infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or a macrolide or azalide are acceptable alternatives in penicillin-allergic individuals. This report updates the 1995 statement by the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. It includes new recommendations for the diagnosis and treatment of GAS pharyngitis, as well as for the secondary prevention of rheumatic fever, and classifies the strength of the recommendations and level of evidence supporting them. (Circulation. 2009;119:1541-1551.)

show abstract

Section: Duration Of Prophylaxismentioning

confidence: 99%

“…[2][3][4][5][6] In developing areas of the world, acute rheumatic fever and rheumatic heart disease are estimated to affect nearly 20 million people and are the leading causes of cardiovascular death during the first 5 decades of life. 7 In contrast, the incidence of acute rheumatic fever has decreased dramatically in most developed countries.…”

mentioning

confidence: 99%

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

Gerber¹,

et al. 2009

View full text Add to dashboard Cite

show abstract

“…During each visit, a detailed history was recorded with special attention to recurrence of symptoms and compliance with prophylaxis. Children who escaped carditis in the initial attack were given prophylaxis for five years; whereas children who had carditis and/or chorea in the initial attack were advised to continue with prophylaxis until the age of 25 years or longer if possible [2,10].…”

Section: Methodsmentioning

confidence: 99%

“…Diagnosis of arthritis and carditis were made as previously described [1,2]. Children with confirmed diagnosis of ARF were entered in the ARF registry of the committee.…”

Section: Diagnostic Criteriamentioning

confidence: 99%

Acute Rheumatic Fever in Kuwait: The Declining Incidence

Majeed¹,

Doudin

Lubani

et al. 1993

Ann Saudi Med

View full text Add to dashboard Cite

“…The latter finding was strengthened by the work of other colleagues who reported that elevated levels of the group A specific polysaccharide antibody (CHO-Ab), in the presence of normal titers of antistreptolysin O (ASO) and anti DNA se B, was only maintained in patients with ARF who developed rheumatic heart disease (RHD) [11][12][13]. Acute rheumatic fever, RHD and acute poststreptococcal glomerulonephritis (AGN) are still common in Arab countries [14][15][16][17][18][19][20][21][22]. However, to the best of our knowledge, no studies of the kinetics of the CHO-Ab have so far been reported from such countries.…”

mentioning

confidence: 99%

The Group Specific Polysaccharide Antibody in Children with Non-Suppurative Sequelae of Group a Streptococcal Infection

et al. 1993

View full text Add to dashboard Cite

; Supported by grant MK015 from the University of Kuwait.; Accepted for publication 9 May 1992.; †Deceased.The kinetics of the group A specific polysaccharide antibody were studied in children with acute rheumatic fever who had no carditis, children with acute rheumatic fever who had carditis and developed rheumatic heart disease and in children with acute poststreptococcal glomerulonephritis. The children with rheumatic fever who had carditis and those who did not, were kept on continuous antistreptococcal prophylaxis. In the group of children who developed rheumatic heart disease the titer of the antibody at onset was significantly higher than those who had rheumatic fever but no carditis (P = 0.01). After a mean follow-up period of three years, a high titer was maintained in children who developed rheumatic heart disease only and was significantly higher than that found in children with rheumatic fever who had no carditis (P = 0.001) and in children with poststreptococcal nephritis (P = 0.001).

show abstract

The natural history of acute rheumatic fever in Kuwait: A prospective six year follow-up report

Cited by 43 publications

References 34 publications

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

Acute Rheumatic Fever in Kuwait: The Declining Incidence

The Group Specific Polysaccharide Antibody in Children with Non-Suppurative Sequelae of Group a Streptococcal Infection

Contact Info

Product

Resources

About